Q2 2024 13F Holders as of 6/30/2024
-
Type / Class
-
Equity / COM
-
Number of holders
-
122
-
Total 13F shares, excl. options
-
72.2M
-
Shares change
-
+23.2M
-
Total reported value, excl. options
-
$563M
-
Value change
-
+$188M
-
Put/Call ratio
-
0.98
-
Number of buys
-
55
-
Number of sells
-
-66
-
Price
-
$7.80
Significant Holders of Summit Therapeutics Inc. - COM (SMMT) as of Q2 2024
151 filings reported holding SMMT - Summit Therapeutics Inc. - COM as of Q2 2024.
Summit Therapeutics Inc. - COM (SMMT) has 122 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 72.2M shares
.
Largest 10 shareholders include BAKER BROS. ADVISORS LP (23.2M shares), VANGUARD GROUP INC (8.82M shares), BlackRock Inc. (7.9M shares), FMR LLC (7.57M shares), STATE STREET CORP (4.12M shares), GEODE CAPITAL MANAGEMENT, LLC (2.96M shares), PRICE T ROWE ASSOCIATES INC /MD/ (2.04M shares), MILLENNIUM MANAGEMENT LLC (1.94M shares), Balyasny Asset Management L.P. (1.01M shares), and NORTHERN TRUST CORP (960K shares).
This table shows the top 122 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.